SWSteven Warach

Steven Warach

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Steven Warach has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Jun Shen

    From the Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological Disorders and Stroke, Bethesda, MD (K.A.D., L.A., E.C.H., S.W.); and the National Institute of Mental Health, National Institutes of Health, Bethesda, MD (J.S.).

    2 shared publications
  • Li An

    From the Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological Disorders and Stroke, Bethesda, MD (K.A.D., L.A., E.C.H., S.W.); and the National Institute of Mental Health, National Institutes of Health, Bethesda, MD (J.S.).

    2 shared publications
  • Arvind B. Bambhroliya

    Neurology, UT Health Science Cntr at Houston, Houston, TX

    1 shared publication
  • Charles C. Miller

    Department of Cardiothoracic and Vascular Surgery, McGovern Medical School at UTHealth Houston, 6400 Fannin St, Ste. #2850, Houston, TX 77030, USA

    1 shared publication
  • Charles E. Begley

    University of Texas School of Public Health, Behavioral Science, Houston, TX, United States of America

    1 shared publication
  • Ellie G. Meyer

    Department of Neurology and the Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, University of Texas - Health, Houston, USA

    1 shared publication

Latest Publications

  • Open Access

    Rationale and Design of a Statewide Cohort to examine efficient resource utilization for patients with Intracerebral hemorrhage (EnRICH)

    by Farhaan S. Vahidy, Ellie G. Meyer, Arvind B. Bambhroliya, Jennifer R. Meeks, Charles E. Begley, Tzu-Ching Wu, Jon E. Tyson, Charles C. Miller, Ritvij Bowry, Wamda O. Ahmed, et al.

    Intracerebral hemorrhage is a devastating disease with no specific treatment modalities. A significant proportion of patients with intracerebral hemorrhage are transferred to large stroke treatment centers, such as Comprehensive Stroke Centers, because of perceived need for higher level of care. However, evidence of improvement in patient-centered outcomes for these patients treated at larger stroke treatment centers as compared to community hospitals is lacking. “Efficient Resource Utilization for Patients with Intracerebral Hemorrhage (EnRICH)” is a prospective, multisite, state-wide, cohort study designed to assess the impact of level of care on long-term patient-centered outcomes for patients with primary / non-traumatic intracerebral hemorrhage. The study is funded by the Texas state legislature via the Lone Star Stroke Research Consortium. It is being implemented via major hub hospitals in large metropolitan cities across the state of Texas. Each hub has an extensive network of “spoke” hospitals, which are connected to the hub via traditional clinical and administrative arrangements, or by telemedicine technologies. This infrastructure provides a unique opportunity to track outcomes for intracerebral hemorrhage patients managed across a health system at various levels of care. Eligible patients are enrolled during hospitalization and are followed for functional, quality of life, cognitive, resource utilization, and dependency outcomes at 30 and 90 days post discharge. As a secondary aim, an economic analysis of the incremental cost-effectiveness of treating intracerebral hemorrhage patients at higher levels of care will be conducted. Findings from EnRICH will provide much needed evidence of the effectiveness and efficiency of regionalized care for intracerebral hemorrhage patients. Such evidence is required to inform policy and streamline clinical decision-making.


  • Open Access

    Metabolic Imaging of Ischemic Stroke: The Present and Future

    by K. A. Dani, S. Warach

    SUMMARY: Measures of cerebral metabolism may be useful in the selection of patients for reperfusion therapies and as end points in clinical trials. However, there are currently no clinically routine techniques that provide such data directly. We review how imaging modalities in current clinical use may provide surrogate markers of metabolic activity. Promising techniques for metabolic imaging that are currently in the pipeline are reviewed.


  • Multivoxel MR Spectroscopy in Acute Ischemic Stroke

    by Krishna A. Dani, Li An, Erica C. Henning, Jun Shen, Steven Warach, on behalf of the National Institute of Neurological Disorders, Stroke Natural History of Stroke Investigators

    Background and Purpose—: Few patients with stroke have been imaged with MR spectroscopy (MRS) within the first few hours after onset. We compared data from current MRI protocols to MRS in subjects with ischemic stroke. Methods—: MRS was incorporated into the standard clinical MRI stroke protocol for subjects <24 hours after onset. MRI and clinical correlates for the metabolic data from MRS were sought. Results—: One hundred thirty-six MRS voxels from 32 subjects were analyzed. Lactate preceded the appearance of the lesion on diffusion-weighted imaging in some voxels but in others lagged behind it. Current protocols may predict up to 41% of the variance of MRS metabolites. Serum glucose concentration and time to maximum partially predicted the concentration of all major metabolites. Conclusion—: MRS may be helpful in acute stroke, especially for lactate detection when perfusion-weighted imaging is unavailable. Current MRI protocols do provide surrogate markers for some indices of metabolic activity.


  • Open Access

    Pilot Results of in Vivo Brain Glutathione Measurements in Stroke Patients

    by Li An, Krishna A Dani, Jun Shen, Steven Warach

    Measurement of glutathione concentration for the study of redox status in subjects with neurological disease has been limited to peripheral markers. We recruited 19 subjects with large strokes. Using magnetic resonance spectroscopy we measured brain glutathione concentration in the stroke region and in healthy tissue to calculate a glutathione-ratio. Elevated glutathione-ratio was observed in subacute (<72 hours) subjects without hemorrhagic transformation (mean = 1.19, P = 0.03, n = 6). No trend was seen when all subjects were considered ( n = 19, 3 to 754 hours, range = 0.45 to 1.41). This technique can detect glutathione changes because of disease, and may be valuable in clinical trials of stroke and other neurological diseases.